We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
143 hedge funds and large institutions have $442M invested in Oric Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 49 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
196% more call options, than puts
Call options by funds: $74K | Put options by funds: $25K
82% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 17
26% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 39
11% more funds holding
Funds holding: 129 → 143 (+14)
4.11% more ownership
Funds ownership: 107.4% → 111.52% (+4.1%)
0% more funds holding in top 10
Funds holding in top 10: 5 → 5 (0)
28% less capital invested
Capital invested by funds: $612M → $442M (-$170M)
Holders
143
Holders Change
+14
Holders Change %
+10.85%
% of All Funds
1.92%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
31
Increased
49
Reduced
39
Closed
17
Calls
$74K
Puts
$25K
Net Calls
+$49K
Net Calls Change
-$3.16M
Top Buyers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$18.7M |
| 2 |
MB
MPM BioImpact
Boston,
Massachusetts
|
+$12.2M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
+$7.71M |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$7.02M |
| 5 |
O
OrbiMed
New York
|
+$6.12M |
Top Sellers
| 1 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
-$21.7M |
| 2 |
VA
VR Adviser
New York
|
-$10.6M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$10.2M |
| 4 |
SCM
Superstring Capital Management
New York
|
-$6.66M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.04M |
